Luye Pharma Group Ltd.
LYPHFOTCHealthcare● Active
$0.20
+$0.00(+0.00%)
Market Cap$815280706
P/E Ratio—
52W High$0.395
52W Low$0.2041
Luye Pharma Group Ltd. (LYPHF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LYPHF · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.94B | $0.84B | $0.70B | $0.67B | ($0.07B) |
| Depreciation & Amort. | $0.84B | $0.79B | $0.70B | $0.67B | $0.58B |
| Stock-Based Comp. | $0.01B | $0.02B | $0.02B | $0.03B | $0.05B |
| Change in Working Capital | $0.25B | ($1.23B) | $0.40B | $0.32B | ($0.42B) |
| Net Cash from Operations | $1.78B | $0.17B | $1.60B | $1.65B | $0.18B |
| Investing Activities | |||||
| Capital Expenditure | ($1.00B) | ($1.71B) | ($1.17B) | ($1.16B) | ($1.54B) |
| Purchases of Investments | ($4.53B) | ($2.39B) | ($1.63B) | ($3.49B) | ($3.98B) |
| Sales of Investments | $1.90B | $3.56B | $2.59B | $2.90B | $1.92B |
| Net Cash from Investing | ($3.99B) | ($1.47B) | ($1.42B) | ($1.66B) | ($3.44B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.25B) | $1.88B | ($0.48B) | ($0.67B) | ($0.41B) |
| Net Cash from Financing | $1.79B | $2.96B | $0.84B | $0.05B | $1.88B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.78B | ($1.54B) | $0.43B | $0.49B | ($1.36B) |
| FCF Margin %(computed) | 12.70% | -25.42% | 7.00% | 8.19% | -26.14% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · CNY · B
Explore more Luye Pharma Group Ltd. data
About Luye Pharma Group Ltd. (LYPHF) Cash Flow Statement
Luye Pharma Group Ltd. generated operating cash flow of $1.78B and free cash flow of $0.78B for 2025 — a FCF margin of 12.70%. Capital expenditure was ($1.00B).
Frequently asked questions
LYPHF · 4 questionsLuye Pharma Group Ltd. generated free cash flow of $0.78B for 2025, up 150.7% year-over-year.
LYPHF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15